Avacta Share Discussion Threads

[m_night10] 12/11/2024 07:50

POLX Polarean Imaging will break out above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target imv. DYOR, not advice.

[amanitaangelicus] 11/11/2024 14:17

Hi Chesh ... show me the licensing deal for 6k and I might, just might, make me cheer up. Not only that, but the deal has to support the super bloated mkt cap and share price I.d be happy with £8m net profit. Without it this share price is unsustainable. Just saying. Crispr gonna eat ya.

[dudishes] 11/11/2024 04:27

Ama just predicting another drop?

[cheshire pete] 09/11/2024 20:02

....back here soon ama?

lol, never been away. Dip in here every now and again. FUDsters need to up their game though and find some new material as no use repeating old stuff.

[amanitaangelicus] 09/11/2024 09:13

Whitey in denial, about a lot of things me thinks.How.s your gambling doing numbnuts? Bought back in for a punt have you,? The usual will soon be here. Raj,Chesh etc

[pwhite73] 09/11/2024 08:57

Rajraj b "Why have they bothered to collaborate with Tempus then?"

There is no collaboration with Tempus. Its just a joint statement by both parties paid for by Avacta to sucker in retail investors. What happened to the collaboration with William Tap of Memorial Sloan Kettering Cancer Center first announced in RNS 06/04/2023.

In fact way before April last year they announced a collaboration with Memorial Sloan Kettering Cancer Center back in November 2016.

RNS 02/11/2016 - "The collaboration will be led by Renier J. Brentjens, MD, PhD, Director of Cellular Oncology at Memorial Sloan Kettering Cancer Center in New York."

All the collaborations are just announcements to give the impression of a functioning UK biotech company which they are not.

[amanitaangelicus] 08/11/2024 16:09

Well, Friday nearly slipped away, another day another dollar. Have a good un. Ps all the traders have slipped away again after a nice little run of appearances banter. Most will have lost a few more quid. News inbound soon. Let's see how keen they are on progressing AV6k, but at what price?
America going keto - try it. Very poor data for long term usage, v hard to maintain.

[amanitaangelicus] 08/11/2024 08:50

You.ll all be following the carnivore diet now Trump has been installed.

[m_night10] 08/11/2024 07:32

POLX Polarean Imaging about to break out above 2p soon. Mcap only $25mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.65p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target imv. DYOR, not advice.

[repins1] 07/11/2024 21:54

Dodgy times now for anything pharma wise, watch this space jfk, Jr we seen our very own. Gov manipulation over lfts, I don't think we've seen anything yet, iffy times ahead, and that's no conspiracy either

[amanitaangelicus] 07/11/2024 14:20

Clue to the share price rise? Strong rise or just helping convi Boyz out? Rinse repeat. Where y'all gone? Your masters have told I to plague some other board

[amanitaangelicus] 07/11/2024 10:35

Boom! 😁

[amanitaangelicus] 06/11/2024 17:11

Nut kicker again today. How y'all doing you dim Trump fans?!

[amanitaangelicus] 05/11/2024 13:51

Some bizarre posts today for sure. I.m not going to bite at the obvious immaturity which abounds. All that matters to me, is why did Smith leave? It.s the great mammoth in the bldy room. We know that he is was a master of delay, subterfuge,economy with the truth, timing etc so just what has he been up to? Any new board appointments for him elsewhere. I hope he hasn't gone for health reasons bcos that would be cruel. Poor Hoy, a great, great cyclist, model athlete, a real gent. He.ll be sorely missed. Having a bubble while I type. Poor guy. Ps if you.re here, got youth on your side, do all you can to stay healthy. All the money in the world wont help much if you.re in pain, can't get out, or facing the end. Trust me on this - others will verify.

[tratante] 05/11/2024 09:59

"It cannot target a warhead only to be released when it comes into contact with FAP. If so how does it do it at the biochemical level."By enzymatic cleavage. It's how enzymes work.

[fieldhouse] 05/11/2024 09:39

I watched a very moving interview with Sir Chris Hoy on BBC breakfast program.Diagnosed with terminal cancer !
The chemo treatment that was actually making him feel ill !

Good luck Avacta

[rajraj b] 05/11/2024 08:52

Wasteful if you're trying to keep yourself accustomed to the lifestyle you're used to.

[rajraj b] 05/11/2024 08:30

Why have they bothered to collaborate with Tempus then?

[divmad] 05/11/2024 08:14

Are you a rational human being or a bot?

[robers98] 05/11/2024 08:05

Website branding update

[1347] 05/11/2024 07:22

Of course Phase 2 is going ahead, Avacta have informed the market several times it will commence in 2024 and there's only a few weeks left now. Meanwhile in the real world they are hoping Avacta investors have collective amnesia and forget about it, and every single thing else they've ever tried to get to market in the last 5 years. I've told you, it's back to the drawing board with two brand new pre-clinical candidates that they can use to keep them in the lifestyles to which they've become accustomed for years to come.

[pwhite73] 04/11/2024 23:44

Rajraj b - Typical unable to get a straight answer from Aman. Allow me answer your question. The answer is no AVA6000 is already dead in the water that's why they've introduced the next generation of preCISION candidates powered by AI if you believe that garbage.

preCISION does not work. It cannot target a warhead only to be released when it comes into contact with FAP. If so how does it do it at the biochemical level. This is what the company would need to explain in a peer review.

[amanitaangelicus] 04/11/2024 23:24

I.m unsure why they would. It.s safe for sure. I reckon anecdotal efficacy data probably isn't top notch enough to make the current combo a class beater. We know the targeting mechanism looks safe, half decent. Better payloads reqd imho though. Who knows. If our new leaders can do a deal and get some partner involved ,this would add credence to the project. Could be wrong. The silence on the progression is deafening, something akin to when an oil discovery data room opens up and the junior is looking for a farm in etc.
Until someone gives me a gd reason why Smith disappeared, I.ll remains unconvinced.
Again, might be wrong, but I fancy the odds, punk.

[rajraj b] 04/11/2024 22:27

So Aman, do you think that AVA6000 won't be progressed any further? No P1b or phase2 etc?